Page last updated: 2024-08-21

dronabinol and baclofen

dronabinol has been researched along with baclofen in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.88)18.7374
1990's1 (5.88)18.2507
2000's4 (23.53)29.6817
2010's10 (58.82)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Greentree, SG; Pertwee, RG; Swift, PA1
Coull, MA; Davies, SN; Johnston, AT; Pertwee, RG1
Anum, E; Lichtman, AH; Niyuhire, F; Varvel, SA; Wise, LE1
Elovic, E; Lombard, L; Zafonte, R1
De Vry, J; Jentzsch, KR1
Bernardi, G; Castelli, M; Cavasinni, F; Centonze, D; De Chiara, V; Errico, F; Mataluni, G; Musella, A; Rossi, S; Sacchetti, L; Siracusano, A; Usiello, A1
Holloway, RH; Kuo, P1
Hays, LR; Kelly, TH; Lile, JA1
Trojano, M1
Álvarez-Ossorio, L; Haupts, M; Jonas, A; Vila, C; Witte, K1
Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P1
Trojano, M; Vermersch, P1
Arroyo González, R1
Jones, É; Vlachou, S1

Reviews

5 review(s) available for dronabinol and baclofen

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antispasticity medications: uses and limitations of enteral therapy.
    American journal of physical medicine & rehabilitation, 2004, Volume: 83, Issue:10 Suppl

    Topics: 4-Aminopyridine; Acetates; Adrenergic alpha-Agonists; Amines; Baclofen; Benzodiazepines; Cyclohexanecarboxylic Acids; Cyproheptadine; Dantrolene; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Glycine; Humans; Muscle Relaxants, Central; Muscle Spasticity; Neuroprotective Agents; Piracetam; Serotonin Antagonists

2004
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:11

    Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Dronabinol; Drug Combinations; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Phenol

2016
A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.
    Expert review of neurotherapeutics, 2018, Volume: 18, Issue:10

    Topics: Baclofen; Cannabidiol; Disease Progression; Dronabinol; Drug Combinations; Gait Disorders, Neurologic; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Nasal Sprays; Plant Extracts; Quality of Life

2018
A Critical Review of the Role of the Cannabinoid Compounds Δ
    Molecules (Basel, Switzerland), 2020, Oct-25, Volume: 25, Issue:21

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Baclofen; Cannabidiol; Clinical Trials as Topic; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Multiple Sclerosis; Spinal Cord; Treatment Outcome; United States; United States Food and Drug Administration

2020

Trials

1 trial(s) available for dronabinol and baclofen

ArticleYear
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
    European neurology, 2016, Volume: 75, Issue:5-6

    Topics: Adult; Baclofen; Cannabidiol; Clonidine; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts

2016

Other Studies

11 other study(ies) available for dronabinol and baclofen

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
    Neuropharmacology, 1988, Volume: 27, Issue:12

    Topics: Aminooxyacetic Acid; Animals; Baclofen; Bicuculline; Catalepsy; Dronabinol; Drug Synergism; Flumazenil; Flupenthixol; Flurazepam; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Muscimol; Nipecotic Acids; Receptors, GABA-A; Strychnine; Taurine; Tiagabine

1988
Action of delta-9-tetrahydrocannabinol on GABA(A) receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal slice.
    Neuropharmacology, 1997, Volume: 36, Issue:10

    Topics: Animals; Antiemetics; Baclofen; Dose-Response Relationship, Drug; Dronabinol; Female; GABA Agonists; Hippocampus; Muscimol; Rats; Rats, Sprague-Dawley; Receptors, GABA-A

1997
Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
    Psychopharmacology, 2005, Volume: 178, Issue:2-3

    Topics: Animals; Baclofen; Bicuculline; Brain; Dronabinol; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Male; Marijuana Abuse; Maze Learning; Memory, Short-Term; Mental Recall; Mice; Mice, Inbred C57BL; Muscimol; Organophosphorus Compounds; Phenotype; Receptor, Cannabinoid, CB1

2005
Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.
    European journal of pharmacology, 2004, Nov-28, Volume: 505, Issue:1-3

    Topics: Alkanesulfonates; Amines; Amitriptyline; Animals; Baclofen; Behavior, Animal; Benzoxazines; Carbamazepine; Cyclohexanecarboxylic Acids; Cyclohexanols; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Indans; Male; Molecular Structure; Morphine; Morpholines; Naphthalenes; Nitriles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids

2004
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:2

    Topics: Animals; Baclofen; Bicuculline; Corpus Striatum; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Interactions; Excitatory Amino Acid Antagonists; Exploratory Behavior; Food Preferences; GABA Agonists; GABA Antagonists; Inhibitory Postsynaptic Potentials; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Neurons; Patch-Clamp Techniques; Physical Conditioning, Animal; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Statistics, Nonparametric; Stress, Psychological; Sucrose; Time Factors

2010
Beyond acid suppression: new pharmacologic approaches for treatment of GERD.
    Current gastroenterology reports, 2010, Volume: 12, Issue:3

    Topics: Animals; Baclofen; Cannabinoid Receptor Agonists; Dogs; Dronabinol; Erythromycin; GABA Agonists; GABA-B Receptor Agonists; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Phosphinic Acids; Propylamines; Proton Pump Inhibitors; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate

2010
Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.
    Drug and alcohol dependence, 2012, Nov-01, Volume: 126, Issue:1-2

    Topics: Adolescent; Adult; Baclofen; Blood Pressure; Body Temperature; Body Temperature Regulation; Demography; Discrimination, Psychological; Dronabinol; Drug Interactions; Female; GABA Agonists; Hallucinogens; Heart Rate; Humans; Male; Marijuana Abuse; Psychomotor Performance; Receptors, GABA-B; Socioeconomic Factors; Substance-Related Disorders; Surveys and Questionnaires; Time Perception; Young Adult

2012
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
    European neurology, 2016, Volume: 75 Suppl 1

    Topics: Adult; Amines; Baclofen; Calcium Channel Blockers; Cannabidiol; Cohort Studies; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Germany; Humans; Italy; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Plant Extracts; Pregabalin; Prospective Studies; Treatment Outcome

2016
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
    European neurology, 2016, Volume: 76, Issue:5-6

    Topics: Activities of Daily Living; Adult; Baclofen; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Quality of Life

2016